Nasdaq: RLAY
Relay Therapeutics insiders
The officers, directors and 10% owners of Relay Therapeutics, Inc. who hold the most stock, valued at the live RLAY price.
$15.91
RLAY today −$600K (−3.63%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their RLAY stock
- $49.7M
- Market value
- $3.52B
- Held by ranked insiders
- 1.41%
Insiders by value of RLAY holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Sanjiv Patel | President and CEO | 1,358,204 | $21.6M | 0.61% | 4882nd |
| 2 | Mark Murcko | Director | 996,952 | $15.9M | 0.45% | 6154th |
| 3 | Donald A. Bergstrom | President, R&D | 396,878 | $6.3M | 0.18% | 12318th |
| 4 | Brian Adams | Chief Legal Officer | 371,472 | $5.9M | 0.17% | 7698th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Relay Therapeutics; see each profile for the filing.